Please find enclosed herewith Outcome of Board Meeting Pursuant to regulation 30 of Sebi (LODR)Regulation, 2015 held on today i.e. 30th October 2026

30th October, 2026 The Manager, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400001 Scrip Code: 539206; Company Symbol: GVBL Sub: Outcome of the Board meeting Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 held on today i.e. 30th October 2026. Dear Sir/Madam, This is to inform you that the Board of Directors of the Company at their meeting held on Wednesday, 30th October 2026, at the corporate office of the Company situated at G-74, Pushkar Enclave, Paschim Vihar, Delhi - 110063 to consider and approve the following matter(s): - 1. Considered and approved the standalone Un-audited financial results of the company for the quarter and half year ended 30th September 2026. A copy of the said standalone un-audited financial results along with the limited review report from Statutory Auditor thereon is enclosed herewith. The meeting of the Board of Directors commenced at 05:15 P.M. and concluded at 05:45 P.M. This is for your information and record please. Thanking you, Yours sincerely, For Genomic Valley Biotech Limited Yogesh Agrawal Managing Director DIN : 01165288 ANDROS & 9O1, TOWER-1, PEARL OMAXE, PLOT B_1, CHARTERED ACCOUNTANTS NETAJI SHUBHASH PLACE, PITAMPURA DELHI-11OO34 Ph-oLL-47060901 Email...: BRIJB.ttUS.HAN CA@yA..HOO.CO-rN LIMITED REVIEW REPORT The Board of Directors of Genomic Valley Biotech Limited, 4 K.M. Stone, Berri Chharra Road, Village- Kherka Musalman, p.O. Tandaheri, Tehsil - Baha durgarh, District-jhajiaa Haryana- 1 Z 4SO7 . Subiect: Limited Review Report on the Un-Audited Financial Results for th" euu.t". rrd half year ended on Sept ate from April 01. 2026 to September 30. 2026 We have revicwed thc accompanying slatement of unar:dited financial results for the euarter and half year ended on September 30, 2A26 and year to date from April 01, 2O26 to September 30, 2026 ('the statement') of Cenomic Valley Biotech Limiteci ['the Company,J attached hercwi[h, being submitted by thc Company pursuant to the requirements of Regulation 33 of SEBI (Listing Obligations and Disclosure Recluirements) Regulations,2015 as amended ["l,isting RegLrlations"). This Statement is the responsibility of the Conrpany's Managemcnt ancl has been approveci by lhe Board of Directors. Our responsibility is to issue a report on these financial statements based on ourreview. This Statenlent has been prepared by the Comp;iny's Management in accorclance ,,vith the recognition and measurcnlenI principlcs laid down in the applicable Inclian Accounting Standa'rds, prescribed under Section 133 of the Companies Act,2013 read with relevant rulei issued thereunder and other recognizecl accounting principles generally accepted in India. We conducted our review in accordance with the Stanclarcl on Review Engagernents 241,0, "Review of Interim Financial Information performecl by the Indepenclent Auditor of the Entity" issuecl by the Institute of Charterecl Accountants ol Inclia. This standarci requires that we plan and perform lhe review to obtain moderate assurance as to whether the Statement is free bf material misstatement. A ieview consists of making inquiries, primarily of persons responsible for financial and accounting matters, ancl applying analytical and other revie.uv proceclures. A review is substantially less in scope than an audit conciucted in accorclance with Srandards on Auciiting and consequently cloes not enable r-rs to obtain assurance that,,ve wourlcl become aware of all significant matters that might be identificd in an audit. Accordingly, we do not cxpress an audit opinion. Based on oLlr rcview conducted as above, nothing has corne [o our erttcntion that causes us to believe that the accompanying Statement of unaLrdited Financial Results preparecl in accordance ',vith recognition and measurerrent principles laid clown in the applicable Inclian Accounting Standards, prescribed uncler Section 133 of Companies Act, 2013 read with relevant rules issued [herer-rnder ancj other recognized accounting practices and policies has not disclosed the information required to be disclosed in termi of Regulation 33 of SEBI (Listing 0bligations and Disclosures Requirements) Regulations, 2015 ai amended ("Listing Regulations") including the manner in which i[ is to be disclosed, or that it contains any material misstatement. For ANDROS & CO., Chartered Accountants Brii Bhushan Garg Partner UDIN: 26OA4B65OCFSSFBB1 B FRN No. 008976N Membership No.084865 PR No. 0195"1.7 PIace: Delhi Date:30.10.2026